Strata Critical Medical (SRTA) officer reports tax-withholding share disposition

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Strata Critical Medical, Inc. Chief Accounting Officer Amir Cohen reported a routine tax-related share disposition. On June 8, 2026, 4,655 shares of Class A common stock were withheld by the company at $5.87 per share to cover tax obligations from vested restricted stock units, leaving 146,608 shares owned directly. This amended Form 4 corrects an earlier filing that had mistakenly classified the event as an open-market sale, clarifying it was a tax-withholding transaction approved under Rule 16b-3.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cohen Amir

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A common stock, $0.0001 par value per share	4,655	$5.87	$27K

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 146,608 shares (Direct, null)

Footnotes (1)

On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Key Figures

Shares withheld for taxes: 4,655 shares Per-share value for withholding: $5.87 per share Shares held after transaction: 146,608 shares

3 metrics

Shares withheld for taxes 4,655 shares Withheld on June 8, 2026 for tax obligations

Per-share value for withholding $5.87 per share Value used for tax-withholding disposition

Shares held after transaction 146,608 shares Direct Class A common stock holdings after June 8, 2026

Key Terms

restricted stock units, tax withholding obligations, Rule 16b-3, Form 4

4 terms

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations"

Rule 16b-3 regulatory

"in a transaction approved in accordance with Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

Form 4 regulatory

"the reporting person filed a Form 4 (the "Original Form")"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 04:10 PM Accepted by SEC EDGAR 06/18/2026 - 04:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last)

(First)

(Middle)

C/O STRATA CRITICAL MEDICAL, INC.

666 THIRD AVENUE, 25TH FLOOR

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
06/10/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A common stock, $0.0001 par value per share	06/08/2026		F⁽¹⁾		4,655⁽²⁾	D	$5.87	146,608	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 10, 2026, the reporting person filed a Form 4 (the "Original Form") which inadvertently used the "S" code in Column 3 of Table I in connection with the disposal of certain shares of the Issuer's Class A common stock (the "Shares") on June 8, 2026. The Shares were in fact withheld by the Issuer to satisfy tax withholding obligations in connection a vesting event in a transaction approved in accordance with Rule 16b-3 of the Securities Exchange Act of 1934, as amended. Footnote 1 to the Original Form correctly described the transaction as "shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units." Accordingly, the reporting person is hereby amending the Original Form to correctly show the "F" code in Column 3 of Table I. The information set forth in the Original Form was correct in all other respects.

2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Strata Critical Medical (SRTA) report in this Form 4/A?

The filing reports that Chief Accounting Officer Amir Cohen had 4,655 shares withheld to cover tax obligations. These shares were Class A common stock tied to vested restricted stock units, not an open-market sale, and were withheld directly by the company.

Why did Strata Critical Medical (SRTA) file an amended Form 4/A for Amir Cohen?

The amendment corrects a code error in a prior Form 4 that labeled the transaction as a sale. The company clarifies the shares were actually withheld to satisfy tax withholding obligations related to restricted stock unit vesting, using the proper “F” code.

How many SRTA shares were involved in Amir Cohen’s June 8, 2026 tax withholding?

A total of 4,655 shares of Class A common stock were withheld on June 8, 2026. These shares covered tax obligations from a vesting event of restricted stock units, rather than being sold on the open market to a third party.

At what price were the withheld SRTA shares valued in Amir Cohen’s Form 4/A?

The withheld shares were valued at a price of $5.87 per share. This figure reflects the value used in the tax-withholding disposition for the 4,655 Class A common shares tied to the restricted stock unit vesting event.

How many Strata Critical Medical (SRTA) shares does Amir Cohen hold after this transaction?

Following the tax-withholding disposition, Amir Cohen directly holds 146,608 shares of Class A common stock. This post-transaction balance shows that the withholding affected only a small portion of his total direct equity position in the company.

Was Amir Cohen’s SRTA transaction an open-market sale or a tax event?

The transaction was a tax event, not an open-market sale. Shares were withheld by Strata Critical Medical to satisfy tax withholding obligations from restricted stock unit vesting, and the Form 4/A corrects the earlier misclassification of the transaction code.